Back to News
Market Impact: 0.3
J&J beats earnings estimates; Middle East conflict weighs on medical device sales
Source: The Globe and Mail
Corporate EarningsHealthcare & BiotechCompany FundamentalsGeopolitics & War
Johnson & Johnson reported profit slightly above expectations, supported by strong sales of its immune disease treatment Tremfya. Geopolitical issues, including the Middle East conflict, weighed on its medical devices business.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
JNJ0.30
More News
- Meta shares rise for a second straight day as new AI model family impresses
- J&J's 6% slide on an imperfect quarter is a gift to prospective buyers
- J&J beats earnings estimates; Middle East conflict weighs on medical-device sales
- Wall St edges lower as chips fall; markets assess big bank earnings
- Wall Street Banks Face New Pressure
- Johnson & Johnson shares SLIDE nearly 6% despite stronger full-year forecast